Nicolas Chignard
Paris, 75012, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
RIPK1 inhibition reduces biliary injury and fibrosis in primary sclerosing cholangitis.
Journal: Science advances
Published: December 17, 2025
ABCB4 disease-causing variants S242R, S346I, T437I and T1077M significantly impair its function and display differential sensitivity to potentiators.
Journal: Scientific reports
Published: May 13, 2025
A subset of hepatic fibroblasts marked by Gli1 expression generates portal fibrosis and promotes ductular reaction.
Journal: JHEP reports : innovation in hepatology
Published: May 03, 2025
Cholangiopathy aggravation is caused by VDR ablation and alleviated by VDR-independent vitamin D signaling in ABCB4 knockout mice.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: September 30, 2020
Expression patterns of nuclear receptors in parenchymal and non-parenchymal mouse liver cells and their modulation in cholestasis.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: November 10, 2016
Nuclear receptors in acute and chronic cholestasis.
Journal: Digestive diseases (Basel, Switzerland)
Published: June 06, 2015
E-cadherin, guardian of liver physiology.
Journal: Clinics and research in hepatology and gastroenterology
Published: September 09, 2014
Phosphorylation of ABCB4 impacts its function: insights from disease-causing mutations.
Journal: Hepatology (Baltimore, Md.)
Published: December 10, 2013
Illuminating liver fibrosis with vitamin D.
Journal: Clinics and research in hepatology and gastroenterology
Published: August 27, 2013
Vitamin D nuclear receptor deficiency promotes cholestatic liver injury by disruption of biliary epithelial cell junctions in mice.
Journal: Hepatology (Baltimore, Md.)
Published: October 31, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026